Structures by: Choon T. S.
Total: 30
(<i>E</i>)-2-[4-(Piperidin-1-yl)benzylidene]-2,3-dihydro-1<i>H</i>-inden-1-one
C21H21NO
Acta Crystallographica Section E (2010) 66, 11 o2878
a=31.587(5)Å b=6.3168(10)Å c=7.8396(12)Å
α=90.00° β=90.00° γ=90.00°
1'-Methyl-4'-[4-(trifluoromethyl)phenyl]dispiro[indan-2,2'-pyrrolidine- 3',2''-indan]-1,3,1''-trione
C28H20F3NO3
Acta Crystallographica Section E (2011) 67, 11 o3125
a=7.8070(2)Å b=22.0878(5)Å c=13.1278(3)Å
α=90.00° β=101.420(2)° γ=90.00°
2-[(<i>E</i>)-4-(Dimethylamino)benzylidene]indan-1-one
C18H17NO
Acta Crystallographica Section E (2011) 67, 8 o1983-o1984
a=30.024(5)Å b=5.9898(9)Å c=7.6862(11)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-(4-bromophenyl)-1-[3-(1<i>H</i>-imidazol-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate monohydrate
C22H21BrN4O2,H2O
Acta Crystallographica Section E (2011) 67, 11 o3060
a=9.18540(10)Å b=16.7389(2)Å c=13.7379(2)Å
α=90.00° β=98.2830(10)° γ=90.00°
7'-(2,5-Dimethoxyphenyl)-1',3',5',6',7',7a'-hexahydrodispiro[indan-2,5'- pyrrolo[1,2-<i>c</i>][1,3]thiazole-6',2''-indan]-1,3,1''-trione
C30H25NO5S
Acta Crystallographica Section E (2012) 68, 3 o560-o561
a=9.0425(4)Å b=11.1127(5)Å c=13.3005(6)Å
α=68.0160(10)° β=84.5880(10)° γ=79.7350(10)°
Ethyl 1-[2-(morpholin-4-yl)ethyl]-2-[4-(trifluoromethyl)phenyl]-1<i>H</i>- benzimidazole-5-carboxylate
C23H24F3N3O3
Acta Crystallographica Section E (2011) 67, 5 o1215
a=10.1463(2)Å b=10.5595(2)Å c=11.5775(2)Å
α=96.8680(10)° β=109.6380(10)° γ=110.8330(10)°
Ethyl 2-(4-methoxyphenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1<i>H</i>- benzimidazole-5-carboxylate
C24H27N3O4
Acta Crystallographica Section E (2012) 68, 2 o308-o309
a=10.7455(3)Å b=12.2235(3)Å c=16.1967(4)Å
α=86.1620(10)° β=80.9170(10)° γ=88.2750(10)°
(<i>E</i>)-2-(4-Chlorobenzylidene)indan-1-one
C16H11ClO
Acta Crystallographica Section E (2011) 67, 8 o2064
a=3.8649(2)Å b=6.5233(3)Å c=12.1703(6)Å
α=91.374(4)° β=95.914(4)° γ=103.483(4)°
(<i>E</i>)-2-(4-Bromobenzylidene)indan-1-one
C16H11BrO
Acta Crystallographica Section E (2011) 67, 9 o2306-o2307
a=6.1933(7)Å b=4.7441(5)Å c=21.8572(19)Å
α=90.00° β=99.108(3)° γ=90.00°
1'-Methyl-4'-phenyldispiro[indan-2,2'-pyrrolidine-3',2''-indan]-1,3,1''-trione
C27H21NO3
Acta Crystallographica Section E (2011) 67, 9 o2383
a=8.4578(7)Å b=11.6194(9)Å c=22.6360(16)Å
α=90.00° β=109.693(2)° γ=90.00°
(3<i>E</i>,5<i>E</i>)-3,5-Dibenzylidene-1-phenethylpiperidin-4-one
C27H25NO
Acta Crystallographica Section E (2011) 67, 10 o2605
a=11.4785(2)Å b=5.83960(10)Å c=30.9591(5)Å
α=90.00° β=106.4120(10)° γ=90.00°
Ethyl 4-[3-(1<i>H</i>-imidazol-1-yl)propylamino]-3-nitrobenzoate
C15H18N4O4
Acta Crystallographica Section E (2011) 67, 10 o2606
a=8.4860(4)Å b=8.6175(4)Å c=11.7507(6)Å
α=77.4890(10)° β=81.7320(10)° γ=67.9770(10)°
7'-Phenyl-5',6',7',7a'-tetrahydrodipiro[indan-2,5'- pyrrolo[1,2-<i>c</i>][1,3]thiazole-6',2''-indan]-1,3,1''-trione
C28H21NO3S
Acta Crystallographica Section E (2011) 67, 12 o3218-o3219
a=19.3315(6)Å b=9.6523(3)Å c=29.9731(8)Å
α=90.00° β=127.817(2)° γ=90.00°
Ethyl 2-(4-nitrophenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C23H24N4O5
Acta Crystallographica Section E (2012) 68, 1 o59
a=9.31250(10)Å b=10.09410(10)Å c=12.9955(2)Å
α=91.9580(10)° β=107.7520(10)° γ=114.4650(10)°
Ethyl 2-(4-hydroxy-3-methoxyphenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate monohydrate
C24H27N3O5,H2O
Acta Crystallographica Section E (2012) 68, 1 o87-o88
a=9.7460(8)Å b=10.0436(8)Å c=12.6072(10)Å
α=85.7370(10)° β=89.684(2)° γ=70.2380(10)°
Ethyl 2-(1,3-benzodioxol-5-yl)-1-[3-(1<i>H</i>-imidazol-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C23H22N4O4
Acta Crystallographica Section E (2012) 68, 1 o247-o248
a=15.8554(2)Å b=15.3988(2)Å c=16.2292(2)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-2-[4-(Trifluoromethyl)benzylidene]-2,3-dihydro-1<i>H</i>-inden-1-one
C17H11F3O
Acta Crystallographica Section E (2012) 68, 2 o545-o546
a=15.6546(13)Å b=6.2050(6)Å c=14.6546(13)Å
α=90.00° β=113.774(2)° γ=90.00°
Ethyl 1-[3-(2-oxopyrrolidin-1-yl)propyl]-2-phenyl-1<i>H</i>- benzimidazole-5-carboxylate
C23H25N3O3
Acta Crystallographica Section E (2012) 68, 2 o251-o252
a=9.9469(3)Å b=10.5845(3)Å c=11.3184(3)Å
α=69.6790(10)° β=67.3740(10)° γ=70.1350(10)°
7'-Phenyl-1',3',5',6',7',7a'-hexahydrodipiro[acenaphthene-1,5'- pyrrolo[1,2-<i>c</i>]thiazole-6',2''-indane]-2,1''(1<i>H</i>)-dione
C31H23NO2S
Acta Crystallographica Section E (2012) 68, 4 o1265-o1266
a=8.40540(10)Å b=11.37160(10)Å c=23.5194(2)Å
α=90.00° β=92.2590(10)° γ=90.00°
4'-(4-Bromophenyl)-1'-methyldispiro[acenaphthylene-1,2'-pyrrolidine- 3',2''-indane]-2,1''(1<i>H</i>)-dione
C30H22BrNO2
Acta Crystallographica Section E (2012) 68, 5 o1340-o1341
a=8.66380(10)Å b=19.9429(2)Å c=13.52250(10)Å
α=90.00° β=94.9370(10)° γ=90.00°
1'-Methyl-4'-[4-(trifluoromethyl)phenyl]dispiro[acenaphthylene- 1,2'-pyrrolidine-3',2''-indane]-2,1''(1<i>H</i>)-dione
C31H22F3NO2
Acta Crystallographica Section E (2012) 68, 5 o1296-o1297
a=8.8373(2)Å b=20.1333(5)Å c=13.7129(3)Å
α=90.00° β=96.2430(10)° γ=90.00°
Ethyl 1-phenyl-2-[4-(trifluoromethyl)phenyl]-1<i>H</i>-benzimidazole-5-carboxylate
C23H17F3N2O2
Acta Crystallographica Section E (2012) 68, 6 o1864-o1865
a=9.8548(2)Å b=25.0714(6)Å c=16.0566(4)Å
α=90.00° β=107.0230(10)° γ=90.00°
Ethyl 2-(4-chlorophenyl)-1-phenyl-1<i>H</i>-benzimidazole-5-carboxylate
C22H17ClN2O2
Acta Crystallographica Section E (2012) 68, 6 o1863
a=9.3357(2)Å b=9.7982(2)Å c=11.7718(4)Å
α=107.502(2)° β=102.106(2)° γ=109.5390(10)°
Ethyl 2-(4-bromophenyl)-1-phenyl-1<i>H</i>-benzimidazole-5-carboxylate
C22H17BrN2O2
Acta Crystallographica Section E (2012) 68, 6 o1683
a=9.3121(2)Å b=9.8136(2)Å c=11.8458(2)Å
α=108.2170(10)° β=101.1350(10)° γ=109.3610(10)°
4'-(3-Bromophenyl)-1'-methyldispiro[indan-2,2'-pyrrolidine-3',2''-indan]- 1,3,1''-trione
C27H20BrNO3
Acta Crystallographica Section E (2012) 68, 10 o2907-o2908
a=8.39980(10)Å b=11.2082(2)Å c=12.4816(2)Å
α=112.0040(10)° β=96.8500(10)° γ=93.1910(10)°
Ethyl 1-phenyl-2-[4-(trifluoromethoxy)phenyl]-1<i>H</i>-benzimidazole-5-carboxylate
C23H17F3N2O3
Acta Crystallographica Section E (2012) 68, 9 o2715-o2716
a=8.0204(4)Å b=10.8943(6)Å c=11.4329(7)Å
α=76.706(4)° β=83.269(4)° γ=81.227(4)°
Ethyl 2-[4-(morpholin-4-yl)phenyl]-1-[3-(2-oxopyrrolidin-1-yl)propyl]- 1<i>H</i>-1,3-benzimidazole-5-carboxylate monohydrate
C27H32N4O4,H2O
Acta Crystallographica Section E (2012) 68, 10 o2967-o2968
a=12.2602(3)Å b=13.7267(4)Å c=15.3163(4)Å
α=99.3570(10)° β=93.7000(10)° γ=94.0030(10)°
Ethyl 2-[4-(dimethylamino)phenyl]-1-phenyl-1<i>H</i>-benzimidazole-5-carboxylate
C24H23N3O2
Acta Crystallographica Section E (2013) 69, 6 o886
a=8.71960(10)Å b=10.4133(2)Å c=11.3658(2)Å
α=79.3120(10)° β=74.3930(10)° γ=89.7810(10)°
4'-(4-Fluorophenyl)-1'-methyldispiro[indan-2,2'-pyrrolidine-3',2''-indan]-1,3,1''-trione methanol hemisolvate
C29H24FNO5,0.5(CH4O)
Acta Crystallographica Section E (2013) 69, 5 o746-o747
a=14.6385(6)Å b=12.5099(6)Å c=26.2017(10)Å
α=90.00° β=92.6450(10)° γ=90.00°
Ethyl 2-[5-(4-fluorophenyl)pyridine-3-yl]-1-[3-(2-oxopyrrolidin-1-yl)propyl] -1<i>H</i>-benzo[<i>d</i>]imidazole-5-carboxylate
C28H27FN4O3,H2O
Acta Crystallographica Section E (2013) 69, 7 o1013-o1014
a=16.0640(15)Å b=7.6562(7)Å c=20.1991(19)Å
α=90.00° β=98.163(2)° γ=90.00°